Special Issue "Orodispersible Tablets: New Advances in Preparation Technologies"
Deadline for manuscript submissions: 26 January 2024 | Viewed by 108
Interests: orodispersible tablets; minitablets; pediatric formulations; parenteral nutrition
Interests: pharmaceutical technology; biopharmaceutics; artificial intelligence; machine learning; data science
Special Issues, Collections and Topics in MDPI journals
Special Issue in Applied Sciences: Biopharmaceutics and Multivariate Modeling of Complex Systems
Special Issue in Applied Sciences: Applications of Artificial Intelligence and Machine Learning in Pharmaceutics
Although orodispersible tablets (ODTs) were introduced to the pharmaceutical market more than 25 years ago, this dosage form still remains a subject of interest for many pharmaceutical technologists as well as innovators from pharma companies. ODTs gain more and more popularity in the pharmacotherapy of many diseases, including both acute and chronic kinds.
The first methods in the production of ODTs involved freeze drying processes, yet nowadays they are mainly produced via direct compression or tableting after granulation. There are two major reasons the application of these methods has been widely used: the development of superdisintegrants, and the introduction of the co-processed excipients with superior compression properties. Both significantly shortened the disintegration process of compressed ODTs, while the latter also improved mechanical properties and facilitated their production.
Recent trends in the development of ODTs include the formulation of the third generation of these tablets, featuring modified release dosage forms, particularly tablets containing microcapsules, coated micropellets or sustained release granules. Their utilization allows for easy administration to pediatric patients or any other persons having difficulties in swallowing solid dosage forms. Other interesting approaches in the formulation of ODTs is the preparation of orodispersible minitablets (ODMTs, MODTs), as well as research into alternative production technologies for these tablets, such as 3D-printing methods.
This Special Issue of Pharmaceuticals invites both reviews and original articles exploring all aspects of orodispersible tablets. Topics of interest include studies on different features of ODTs, beginning from the conceptualization of the innovative forms through to the formulation process and ending on the pharmacokinetics of these forms and clinical trials of new formulations.
Dr. Witold Brniak
Prof. Dr. Aleksander Mendyk
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- orodispersible tablets
- orally disintegrating tablets
- co-processed excipients
- direct compression
- 3D printing